Cubist Systematic Strategies’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$428K Buy
+2,035
New +$359K ﹤0.01% 2351
2025
Q2
– Sell
-2,425
Closed -$213K – 3181
2025
Q1
$213K Buy
+2,425
New +$224K ﹤0.01% 2496
2024
Q2
– Sell
-1,751
Closed -$165K – 3375
2024
Q1
$165K Buy
+1,751
New +$154K ﹤0.01% 3149
2023
Q3
– Sell
-1,410
Closed -$135K – 3562
2023
Q2
$135K Sell
1,410
-1,706
-55% -$170K ﹤0.01% 2925
2023
Q1
$314K Buy
3,116
+1,074
+53% +$164K ﹤0.01% 2965
2022
Q4
$355K Sell
2,042
-4,355
-68% -$2.87M ﹤0.01% 3255
2022
Q3
$6.13M Buy
6,397
+5,588
+691% +$5.55M 0.03% 880
2022
Q2
$542K Sell
809
-394
-33% -$244K ﹤0.01% 3000
2022
Q1
$836K Buy
1,203
+491
+69% +$379K 0.01% 2177
2021
Q4
$644K Sell
712
-226
-24% -$215K 0.01% 2258
2021
Q3
$943K Buy
938
+762
+433% +$561K 0.01% 1568
2021
Q2
$114K Sell
176
-362
-67% -$251K ﹤0.01% 2702
2021
Q1
$398K Buy
538
+341
+173% +$275K 0.01% 2086
2020
Q4
$152K Sell
197
-412
-68% -$325K ﹤0.01% 2332
2020
Q3
$604K Buy
609
+120
+25% +$127K 0.01% 1631
2020
Q2
$508K Buy
+489
New +$492K 0.01% 1582

Other funds holding GOSS

Cubist Systematic Strategies's GOSS Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Gossamer Bio (GOSS) in Q3 2025: 2,035 shares worth $428K. The stake represents ﹤0.01% of the portfolio and ranks #2351 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in GOSS as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in GOSS in Q2 2020 and has held it in 16 quarters since. The position peaked at $6.13M in Q3 2022. 162 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • Cubist Systematic Strategies held 2,035 shares of Gossamer Bio worth $428K as of Q3 2025.
  • Gossamer Bio was a new Cubist Systematic Strategies position in Q3 2025.
  • Gossamer Bio made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2351 holding.
  • Cubist Systematic Strategies first reported a position in Gossamer Bio in Q2 2020 and has held it in 16 quarters since.
  • Cubist Systematic Strategies's Gossamer Bio position peaked at $6.13M in Q3 2022.
  • 162 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.